Processa Pharmaceuticals, Inc. Interest Paid, Including Capitalized Interest, Operating and Investing Activities
Processa Pharmaceuticals, Inc. (PCSA) reported Interest Paid, Including Capitalized Interest, Operating and Investing Activities of $6.72 thousand for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-20.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:InterestPaid · last filed 2017-11-20
- Processa Pharmaceuticals, Inc. interest paid, including capitalized interest, operating and investing activities for the quarter ending 2016-06-30 was $1.51K, a 86.00% decline year-over-year.
- Processa Pharmaceuticals, Inc. interest paid, including capitalized interest, operating and investing activities for the quarter ending 2016-03-31 was $5.21K, a 58.50% decline year-over-year.
- Processa Pharmaceuticals, Inc. interest paid, including capitalized interest, operating and investing activities for the quarter ending 2015-12-31 was $0.00.
- Processa Pharmaceuticals, Inc. interest paid, including capitalized interest, operating and investing activities for the quarter ending 2015-09-30 was $23.36K, a 69.57% decline year-over-year.
- Processa Pharmaceuticals, Inc. interest paid, including capitalized interest, operating and investing activities for fiscal 2015 was $25.36K, a 86.96% decline from fiscal 2014.
- Processa Pharmaceuticals, Inc. interest paid, including capitalized interest, operating and investing activities for fiscal 2014 was $194.45K, a 80.19% increase from fiscal 2013.
- Processa Pharmaceuticals, Inc. interest paid, including capitalized interest, operating and investing activities for fiscal 2013 was $107.91K, a 39.48% decline from fiscal 2012.
- Processa Pharmaceuticals, Inc. interest paid, including capitalized interest, operating and investing activities for fiscal 2012 was $178.32K.
| Period end | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 3 month | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 6 month | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 6 month as first filed | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 9 month | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 12 month | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 27 month | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 30 month | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 33 month | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 36 month |
|---|---|---|---|---|---|---|---|---|---|
| 2017-09-30 | $6.72K 10-Q · filed 2017-11-20 | ||||||||
| 2016-06-30 | $1.51K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-10-04 | $6.72K 10-Q · filed 2017-10-04 | $6.72K derived: sum of 3 quarters · filed 2017-10-04 | $30.08K derived: sum of 4 quarters · filed 2017-10-04 | |||||
| 2016-03-31 | $5.21K 10-Q · filed 2017-10-04 | $5.21K derived: sum of 2 quarters · filed 2017-10-04 | $28.57K derived: sum of 3 quarters · filed 2017-10-04 | $39.37K derived: sum of 4 quarters · filed 2017-10-04 | |||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-25 | $23.36K derived: sum of 2 quarters · filed 2017-09-25 | $34.16K derived: sum of 3 quarters · filed 2017-09-25 | $25.36K 10-K · filed 2017-09-25 | |||||
| 2015-09-30 | $23.36K 10-Q · filed 2017-09-08 | $34.16K derived: sum of 2 quarters · filed 2017-09-08 | $25.36K 10-Q · filed 2015-12-01 | $11.59K derived: sum of 4 quarters · filed 2017-09-08 | |||||
| 2015-06-30 | $10.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-30 | $23.36K 10-Q · filed 2017-08-30 | $25.36K 10-Q · filed 2015-08-19 | -$11.77K derived: sum of 3 quarters · filed 2017-08-30 | $64.99K derived: sum of 4 quarters · filed 2017-08-30 | ||||
| 2015-03-31 | $12.56K 10-Q · filed 2017-08-07 | -$22.57K derived: sum of 2 quarters · filed 2017-08-07 | $54.19K derived: sum of 3 quarters · filed 2017-08-07 | $167.89K derived: sum of 4 quarters · filed 2017-08-07 | |||||
| 2014-12-31 | -$35.12K derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-19 | $41.63K derived: sum of 2 quarters · filed 2017-06-19 | $155.33K derived: sum of 3 quarters · filed 2017-06-19 | $194.45K 10-K · filed 2017-06-19 | |||||
| 2014-09-30 | $76.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-12-01 | $190.46K derived: sum of 2 quarters · filed 2015-12-01 | $229.57K 10-Q · filed 2015-12-01 | $242.44K derived: sum of 4 quarters · filed 2015-12-01 | |||||
| 2014-06-30 | $113.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-19 | $152.81K 10-Q · filed 2015-08-19 | $165.68K derived: sum of 3 quarters · filed 2015-08-19 | $211.08K derived: sum of 4 quarters · filed 2015-08-19 | |||||
| 2014-03-31 | $39.12K 10-Q · filed 2015-05-15 | $51.99K derived: sum of 2 quarters · filed 2015-05-15 | $97.39K derived: sum of 3 quarters · filed 2015-05-15 | $131.14K derived: sum of 4 quarters · filed 2015-05-15 | $487.35K 10-Q · filed 2014-05-14 | ||||
| 2013-12-31 | $12.87K derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-14 | $58.27K derived: sum of 2 quarters · filed 2015-04-14 | $92.02K derived: sum of 3 quarters · filed 2015-04-14 | $107.91K 10-K · filed 2015-04-14 | $448.23K 10-K · filed 2014-03-27 | ||||
| 2013-09-30 | $45.40K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $79.15K derived: sum of 2 quarters · filed 2014-11-13 | $95.04K 10-Q · filed 2014-11-13 | $119.29K derived: sum of 4 quarters · filed 2014-11-13 | $438.28K 10-Q · filed 2013-11-08 | ||||
| 2013-06-30 | $33.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-19 | $49.64K 10-Q · filed 2014-08-19 | $73.89K derived: sum of 3 quarters · filed 2014-08-19 | $108.62K derived: sum of 4 quarters · filed 2014-08-19 | $392.88K 10-Q/A · filed 2013-09-06 | ||||
| 2013-03-31 | $15.89K 10-Q · filed 2014-05-14 | $40.13K derived: sum of 2 quarters · filed 2014-05-14 | $74.86K derived: sum of 3 quarters · filed 2014-05-14 | ||||||
| 2012-12-31 | $24.25K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $58.97K derived: sum of 2 quarters · filed 2014-03-27 | $178.32K 10-K · filed 2014-03-27 | ||||||
| 2012-09-30 | $34.73K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-11-08 | $154.07K 10-Q · filed 2013-11-08 | |||||||
| 2012-06-30 | $119.34K 10-Q/A · filed 2013-09-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |